NCT07559318 Post-Emergency Optimization of Antibiotic Therapy for Urinary Tract Infection (UTI)
| NCT ID | NCT07559318 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Intercommunal Creteil |
| Condition | Urinary Tract Infections |
| Study Type | OBSERVATIONAL |
| Enrollment | 330 participants |
| Start Date | 2026-06-01 |
| Primary Completion | 2027-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 330 participants in total. It began in 2026-06-01 with a primary completion date of 2027-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Prospective, multicenter, non-interventional study conducted over 6 months, including patients presenting to the emergency department with suspected urinary tract infection managed as outpatients and discharged with or without empiric antibiotic therapy. Discharge antibiotic prescriptions are reviewed, with subsequent reassessment and optimization of treatment based on urine culture and susceptibility results
Eligibility Criteria
Inclusion Criteria: * Age 18 years or over * Patients presenting at emergency department, with symptoms suggestive of a urinary tract infection suitable for outpatient management (uncomplicated cystitis or cystitis at risk of complications, uncomplicated pyelonephritis or pyelonephritis at risk of complications, male urinary tract infection with or without fever) who have had a urine culture taken Exclusion Criteria: * Refusal to participate in the study * Vulnerable person (person under guardianship or trusteeship, minor, person deprived of liberty, person unable to express their refusal) * Pregnant women * Severe urinary tract infection (sepsis, septic shock or requiring drainage, except for low urinary catheterisation) * Hospitalisation for a urinary tract infection or decompensation of another comorbidity * Suspected urinary tract infection without a urine culture having been performed
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07559318 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Urinary Tract Infections. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07559318 currently recruiting?
Yes, NCT07559318 is actively recruiting participants. Contact the research team at anna.belkacem@chiv.fr for enrollment information.
Where is the NCT07559318 trial being conducted?
This trial is being conducted at Melun, France, Saint-Denis, France, Villeneuve-Saint-Georges, France.
Who is sponsoring the NCT07559318 clinical trial?
NCT07559318 is sponsored by Centre Hospitalier Intercommunal Creteil. The trial plans to enroll 330 participants.